leflunomide has been researched along with ANCA-Associated Vasculitides in 5 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Leflunomide was superior to azathioprine (HR 0." | 2.50 | Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis. ( Feldman, BM; Gross, WL; Guillevin, L; Hazlewood, GS; Metzler, C; Pagnoux, C; Tomlinson, GA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JJY | 1 |
| Alsaleem, A | 1 |
| Chiang, GPK | 1 |
| Limenis, E | 1 |
| Sontichai, W | 1 |
| Yeung, RSM | 1 |
| Akikusa, J | 1 |
| Laxer, RM | 1 |
| Thiel, J | 1 |
| Salzer, U | 1 |
| Hässler, F | 1 |
| Effelsberg, NM | 1 |
| Hentze, C | 1 |
| Sic, H | 1 |
| Bartsch, M | 1 |
| Miehle, N | 1 |
| Peter, HH | 1 |
| Warnatz, K | 1 |
| Schlesier, M | 1 |
| Voll, RE | 1 |
| Venhoff, N | 1 |
| Hazlewood, GS | 1 |
| Metzler, C | 1 |
| Tomlinson, GA | 1 |
| Gross, WL | 1 |
| Feldman, BM | 1 |
| Guillevin, L | 1 |
| Pagnoux, C | 1 |
| Pettersson, T | 1 |
| Karjalainen, A | 1 |
| Dábague Guzmán, J | 1 |
| Pedroza Granados, J | 1 |
| Zúñiga Varga, J | 1 |
4 reviews available for leflunomide and ANCA-Associated Vasculitides
| Article | Year |
|---|---|
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathio | 2019 |
Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Female; Humans; Immunosupp | 2014 |
[Diagnosis and management of small vessel vasculitides].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antibodies, Mono | 2010 |
[Maintainance treatment of anti-neutrophil cytoplasm associated antibodies (ANCA)].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; | 2011 |
1 other study available for leflunomide and ANCA-Associated Vasculitides
| Article | Year |
|---|---|
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; | 2013 |